Your browser doesn't support javascript.
loading
Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial.
Packer, Milton; Anker, Stefan D; Butler, Javed; Filippatos, Gerasimos; Ferreira, Joao Pedro; Pocock, Stuart J; Rocca, Hans-Peter Brunner-La; Janssens, Stefan; Tsutsui, Hiroyuki; Zhang, Jian; Brueckmann, Martina; Jamal, Waheed; Cotton, Daniel; Iwata, Tomoko; Schnee, Janet; Zannad, Faiez.
  • Packer M; Baylor Heart and Vascular Institute, Baylor University Medical Center, 621 N. Hall Street, Dallas, TX, USA.
  • Anker SD; Imperial College, London, UK.
  • Butler J; Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Berlin, Germany.
  • Filippatos G; Department of Medicine, University of Mississippi School of Medicine, Jackson, MS, USA.
  • Ferreira JP; National and Kapodistrian, University of Athens School of Medicine, Athens University Hospital Attikon, Athens, Greece.
  • Pocock SJ; Université de Lorraine, Inserm INI-CRCT, CHRU, Nancy, France.
  • Rocca HB; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
  • Janssens S; Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Tsutsui H; Department of Cardiology, University Hospital Gasthuisberg of Leuven, Leuven, Belgium.
  • Zhang J; Department of Cardiovascular Medicine, Kyushu University, Higashi-ku, Fukuoka, Japan.
  • Brueckmann M; Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Jamal W; Boehringer Ingelheim International GmbH and Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.
  • Cotton D; Boehringer Ingelheim International GmbH, Ingelheim, Germany.
  • Iwata T; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA.
  • Schnee J; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
  • Zannad F; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA.
Eur Heart J ; 42(6): 671-680, 2021 02 11.
Article en En | MEDLINE | ID: mdl-33459776
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neprilisina / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neprilisina / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article